Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-03-26
2000-11-14
Clark, Deborah J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 43, 514 45, 514 46, 514 47, 424450, A61K 4800, A61K 9127, A61K 3170
Patent
active
061470562
ABSTRACT:
Methods of treatment or prevention of hyperproliferative diseases or pre-cancerous conditions affecting epithelial cells, such as psoriasis, vitiligo, atopic dermatitis, or hyperproliferative or UV-responsive dermatoses, hyperproliferative or allergically mediated diseases of other epithelia and methods for reducing photoaging or for prophylaxis against or reduction in the likelihood of the development of skin cancer, are disclosed.
REFERENCES:
patent: 3937809 (1976-02-01), Jacobi
patent: 4419343 (1983-12-01), Pauly
patent: 4508703 (1985-04-01), Redziniak et al.
patent: 4621023 (1986-11-01), Redziniak et al.
patent: 5077211 (1991-12-01), Yarosh
patent: 5455029 (1995-10-01), Hartman et al.
patent: 5470577 (1995-11-01), Gilchrest et al.
patent: 5599672 (1997-02-01), Liang et al.
patent: 5643556 (1997-07-01), Gilchrest et al.
patent: 5879713 (1999-03-01), Roth et al.
patent: 5955059 (1999-09-01), Gilchrest et al.
Principles of Biochemistry, 6th edition. White et al., eds. pp. 182-183, 1978.
Fritsch, M. et al., "Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents," Oncogene 8:307-318 (1993).
Mitsudomi, T. et al., "p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features," Oncogene 7:171-180 (1992).
Nelson, W.G. and Kastan, M.B., "DNA Strand Breaks: the DNA Template Alterations That Triger p53-Dependent DNA Damage Response Pathways," Mol. and Cell. Biol. 14(3):1815-1823 (1994).
Wei, Q. et al., "DNA repair and aging in basal cell carcinoma: A molecular epidemology study," Proc. Natl. Acad. Sci. USA 90:1614-1618 (1993).
Yaar, M. et al., "The trk Family of Receptors Mediates Nerve Growth Factor and Neurotrophin-3 Effects in Melanocytes," J. Clin. Invest 94:1550-1562 (1994).
Mitchell, D.L. and Karentz, D., "The Induction and Repair of DNA Photodamage in the Environment," In Environment UV Photobiology, A.R. Young et al., eds. (NY: Plenum Press), pp. 345-377 (1993).
Pedeux, R., et al., "Thymidine Dinucleotides Induce S Phase Cell Cycle Arrest in Addition to Increased Melanogenesis in Human Melanocytes," The Society for Investigative Dermatology, Inc., (pp. 472-477) (1998).
Niggli, H.J. et al., "Sunlight-Induced Pyrimidine Dimers In Human Skin Fibroblasts In Comparison With Dimerization After Artificial UV-Irradiation", Photochemistry and Photobiology, 48(3):353-356 (1988).
Jayaraman, L. and Prives, C., "Activation of p53 Sequence-Specific DNA Binding by Short Single Strands of DNA Requires the p53 C-Terminus", Cell, 81:1021-1029 (1995).
Kern SE., et al., "Oncogenic Forms of p53 Inhibit p53-regulated Gene Expression," Science, 256(5058):827-30 (1992).
Walworth, N.C. and Bernards, R., "rad-Dependent Response of the chkl-Encoded Protein Kinase at the DNA Damage Checkpoint," Science, 271:353-356 (1996).
El-Deiry, W.S., et al., "WAF1, a Potential Mediator of p53 Tumor Suppression," Cell, 75:817-825 (1993).
Lu, X. and D.P. Lane, "Differential Induction of Transcriptionally Active p53 Following UV or Ionizing Radiation: Defects in Chromosome Instability Syndromes?" Cell, 75:765-778 (1993).
Kastan, M.B. et al., "A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 Is Defective in Ataxia-Telangiectasia," Cell, 71:587-597 (1992).
Hupp, T.R. et al., "Small Peptides Activate the Latent Sequence-Specific DNA Binding Function of p53," Cell, 83:237-245 (1995).
Sanchez, Y. et al., "Regulation of RAD53 by the ATM-Like Kinases MEC1 and TEL1 in Yeast Cell Cycle Checkpoint Pathways," Science, 271:357-360 (1996) .
Eller Mark
Gilchrest Barbara A.
Yaar Mina
Clark Deborah J.
Trustees of Boston University
LandOfFree
Use of locally applied DNA fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of locally applied DNA fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of locally applied DNA fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2065530